Cincinnati, OH – April 19, 2017 – The circular anastomosis is one of the most critical steps in cancer surgery and has a high risk for complications. Complications can include leaks and bleeding which can require reoperation. In an effort to make measurable clinical and cost-of-care improvements for healthcare providers and patients globally, Ethicon*, a […]
Follows regulatory submissions in US, EU and Canada London UK – 18 April 2017 – GSK [LSE/NYSE: GSK] today announced that Japan Vaccine Co., Ltd., a joint venture of GlaxoSmithKline and Daiichi Sankyo Co., Ltd., submitted a New Drug Application in Japan seeking approval for the candidate shingles vaccine, Shingrix, for the prevention of herpes […]
Two groups recommend the drugs, but diverge on who needs them and when DURHAM, N.C. April 18, 2017 – Dueling guidelines for the use of statins to prevent cardiovascular disease have fed confusion, but this much is now known: If all doctors followed advice from the U.S. Preventive Services Task Force, 9 million fewer adults […]
RALEIGH, N.C. (April 18, 2017) — WakeMed Health & Hospitals and Duke Health have signed a joint operating agreement to establish Cancer Care Plus+, a shared cancer care collaboration that will serve the growing cancer care needs of patients and provide the highest quality cancer care consistent with Duke’s renowned cancer program and WakeMed’s surgical […]
Collaboration Focused on Phase 2b Clinical Trial to Evaluate Use of Allergan’s Cenicriviroc (CVC) and Novartis Lead FXR Agonist to Treat NASH NASH Fastest Growing Cause of Liver Cancer and Liver Transplant in the U.S. DUBLIN, April 18, 2017 /PRNewswire/ — Allergan, a leading global biopharmaceutical company, announced today that it has entered into a […]
LOME, TOGO – April 18, 2017 — GSK, Merck (known as MSD outside the United States and Canada), and the MECTIZAN® Donation Program (MDP) congratulate President Faure Gnassingbé, the government and the people of Togo for becoming the first country in Africa recognized by the World Health Organization to have eliminated lymphatic filariasis (LF) as […]
WILMINGTON, N.C. April 18, 2017 – New Hanover Regional Medical Center marked the completion of a two-year renovation to its main campus Emergency Department today at a dedication ceremony for staff and employees. “Our expansion and renovation offers patients more privacy, comfort and efficiency than ever before,” said Christy Spivey, NHRMC administrator of emergency services. […]
One-on-one therapy eliminated PTSD diagnoses for almost half of trial participants DURHAM, N.C. April 17, 2017 – Although both group and individual therapy can ease post-traumatic stress disorder (PTSD) symptoms in active-duty military service members, individual therapy relieved PTSD symptoms better and quicker, according to a study led by a Duke University School of Medicine […]
WILMINGTON, N.C. April 17, 2017 – New Hanover Regional Medical Center has earned an A grade from The Leapfrog Group, a nonprofit organization committed to driving quality, safety, and transparency in the U.S. health care system, for spring of 2017. Leapfrog assigns A, B, C, D and F letter grades to more than 2,600 hospitals […]
INDIANAPOLIS APRIL 14, 2017–(BUSINESS WIRE)– Eli Lilly and Company (NYSE:LLY) and Incyte Corporation (NASDAQ:INCY) announced today that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for the New Drug Application (NDA) of the investigational medicine baricitinib, a once-daily oral medication for the treatment of moderate-to-severe rheumatoid arthritis (RA). The letter […]